The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ERALOP study: Hair regrowth after adjuvant FEC-docetaxel chemotherapy for early breast cancer in the real life.
Hugues Pierre Bourgeois
No relevant relationships to disclose
Aurelie Jamet
No relevant relationships to disclose
Francoise Grude
No relevant relationships to disclose
Carole Adounkpe
No relevant relationships to disclose
Pierre Kerbrat
No relevant relationships to disclose
Remy Delva
No relevant relationships to disclose
Helene Simon
No relevant relationships to disclose
Philippe Deguiral
No relevant relationships to disclose
Bertrand Diquet
No relevant relationships to disclose
Pascale Laine
No relevant relationships to disclose